Compare ARK Genomic Revolution ETF (ARKG) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lemonade Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.9, while Lemonade Inc trades at $69.85 (market cap $5.42B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LMND | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $96.57 |
52-Week Low | $23.09 | $36.28 |
Market Cap | — | $5.42B |
Enterprise Value | — | $5.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Lemonade (LMND) trades at $70.51, up 0.26% today, with a bullish technical signal from moving averages and strong support at $69. The company shows accelerating revenue growth, with 2025 revenue reaching $738 million, while narrowing net losses to -$166 million. Recent news highlights expansion into new states and reinsurance program improvements, though the stock faces a mixed analyst consensus with 33% buy ratings.
Outlook remains speculative given persistent losses but improving margins; key opportunities include AI-driven growth and market expansion, while risks involve high valuation multiples and profitability timeline uncertainty. The consensus price target of $67 suggests limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
